journal article·2009-02-04

Role of Cocrystal and Solution Chemistry on the Formation and Stability of Cocrystals with Different Stoichiometry

Adivaraha Jayasankar, L. Sreenivas Reddy, Sarah J. Bethune, Naír Rodríguez-Hornedo

Crystal Growth & Design· Volume 9· Issue 2
Publisher page

Abstract

The objective of this study is to identify factors and conditions governing the formation and stability of cocrystals with different stoichiometry. Carbamazepine−4-aminobenzoic acid (CBZ−4ABA) cocrystals were chosen as the model system. A 1:1 CBZ−4ABA cocrystal was discovered by the reaction crystallization method. This cocrystal is characterized by carboxylic acid···acid and amide···amide homosynthons. The stability of 2:1 and 1:1 cocrystals is shown to be dependent on ligand solution concentration. The cocrystal richer in ligand component is more stable at higher ligand solution concentrations. Solubility of cocrystals and crystalline drug is explained by 1:1 solution complexation, and both cocrystals follow solubility product behavior. Mathematical models based on cocrystal and solution chemistry were fit to experimental data to generate phase solubility and triangular phase diagrams.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Crystallography and molecular interactions · Crystallization and Solubility Studies · Molecular spectroscopy and chirality

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109

References (38)

Show source-provided references
1. Trask A. V. · Mol. Pharm. · 2007 · 4 · 30110.1021/mp070001z ↗
2. Childs S. L. · J. Am. Chem. Soc. · 2004 · 126 · 1333510.1021/ja048114o ↗
3. Hickey M. B. · Eur. J. Pharm. Biopharm. · 2007 · 67 · 11210.1016/j.ejpb.2006.12.016 ↗
4. McNamara D. P. · Pharm. Res. · 2006 · 23 · 188810.1007/s11095-006-9032-3 ↗
5. Nicoli S. · J. Pharm. Sci. · 2008 · 97 · 483010.1002/jps.21341 ↗
6. Remenar J. F. · Mol. Pharm. · 2007 · 4 · 38610.1021/mp0700108 ↗
7. Rodríguez-Hornedo N. · 2006 · 615
8. Sun C. C. · Cryst. Growth Des. · 2008 · 8 · 157510.1021/cg700843s ↗
9. Trask A. V. · Cryst. Growth Des. · 2005 · 5 · 101310.1021/cg0496540 ↗
10. Trask A. V. · Int. J. Pharm. · 2006 · 320 · 11410.1016/j.ijpharm.2006.04.018 ↗
11. Childs S. L. · Cryst. Growth Des. · 2007 · 7 · 129110.1021/cg060742p ↗
12. Babu N. J. · Mol. Pharm. · 2007 · 4 · 41710.1021/mp070014c ↗
13. Childs S. L. · CrystEngComm · 2008 · 85610.1039/b715396a ↗
14. Fleischman S. G. · Cryst. Growth Des. · 2003 · 3 · 90910.1021/cg034035x ↗
15. McMahon J. A. · Z. Kristallogr. · 2005 · 220 · 34010.1524/zkri.220.4.340.61624 ↗
16. Trask A. V. · Cryst. Growth Des. · 2005 · 5 · 223310.1021/cg0501682 ↗
17. Berry D. J. · Cryst. Growth Des. · 2008 · 8 · 169710.1021/cg800035w ↗
18. Karki S. · Mol. Pharm. · 2007 · 4 · 34710.1021/mp0700054 ↗
19. Lu E. · CrystEngComm · 2008 · 10 · 66510.1039/b801713c ↗
20. Nehm S. J. · Cryst. Growth Des. · 2006 · 6 · 59210.1021/cg0503346 ↗
21. Rodríguez-Hornedo N. · Mol. Pharm. · 2006 · 3 · 36210.1021/mp050099m ↗
22. Jayasankar A. · Mol. Pharm. · 2007 · 4 · 36010.1021/mp0700099 ↗
23. Jayasankar A. · Pharm. Res. · 2007 · 23 · 238110.1007/s11095-006-9110-6 ↗
24. Seefeldt K. J. · J. Pharm. Sci. · 2007 · 96 · 114710.1002/jps.20945 ↗
25. Bak A. · J. Pharm. Sci. · 2008 · 97 · 394210.1002/jps.21280 ↗
26. Leiserowitz L. · Acta Crystallogr. · 1976 · 32 · 77510.1107/S0567740876003968 ↗
27. Vishweshwar P. · J. Pharm. Sci. · 2006 · 95 · 49910.1002/jps.20578 ↗
28. Higuchi T. · 1965 · 4 · 117
29. Chiarella R. A. · Cryst. Growth Des. · 2007 · 7 · 122310.1021/cg070218y ↗
30. Poole J. W. · J. Am. Pharm. Assoc. · 1959 · 59210.1002/jps.3030481010 ↗
31. Zughul M. B. · Int. J. Pharm. · 1997 · 151 · 10910.1016/S0378-5173(97)04901-6 ↗
32. Kostenbauder H. B. · J. Am. Pharm. Assoc. · 1956 · 45 · 51810.1002/jps.3030450804 ↗
33. Leiserowitz L. · J. Chem. Soc. · 1969 · 16 · 237210.1039/j19690002372 ↗
34. Ito K. · Chem. Pharm. Bull. · 1966 · 14 · 25510.1248/cpb.14.255 ↗
35. Mullin J. W. · 2001
36. Bolton S. · J. Am. Pharm. Assoc. · 1957 · 46 · 3810.1002/jps.3030460111 ↗
37. Sheldrick G. M. · 2003
38. Sheldrick G. M. · 2001